InvestorsObserver
×
News Home

Should Biotechnology Stock Better Therapeutics Inc (BTTX) Be in Your Portfolio Tuesday?

Tuesday, June 21, 2022 11:13 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Better Therapeutics Inc (BTTX) Be in Your Portfolio Tuesday?

The 42 rating InvestorsObserver gives to Better Therapeutics Inc (BTTX) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 37 percent of stocks in the Biotechnology industry, BTTX’s 42 overall rating means the stock scores better than 42 percent of all stocks.

Overall Score - 42
BTTX has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on BTTX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Better Therapeutics Inc Stock Today?

Better Therapeutics Inc (BTTX) stock is trading at $1.52 as of 11:12 AM on Tuesday, Jun 21, a loss of $0.00, or -0.01% from the previous closing price of $1.52. Volume today is less active than usual. So far 60,578 shares have traded compared to average volume of 5,231,183 shares. The stock has traded between $1.51 and $1.59 so far today. Click Here to get the full Stock Report for Better Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App